ACR 2019 | The COAST-X trial | Ixekizumab in nonradiographic axial spondyloarthritis | Laura Coates | rheumatology.medicinematters.com
![PDF) What influences patients' opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international study of 424 patients PDF) What influences patients' opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international study of 424 patients](https://i1.rgstatic.net/publication/349961802_What_influences_patients'_opinion_of_remission_and_low_disease_activity_in_psoriatic_arthritis_Principal_component_analysis_of_an_international_study_of_424_patients/links/6133b5fd38818c2eaf81d357/largepreview.png)
PDF) What influences patients' opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international study of 424 patients
Family raises money for Psoriatic Arthritis research in Oxford — Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
![Outcome Assessments: Measuring Global Disease Activity in Patients with Psoriatic Arthritis - The Rheumatologist Outcome Assessments: Measuring Global Disease Activity in Patients with Psoriatic Arthritis - The Rheumatologist](https://www.the-rheumatologist.org/wp-content/uploads/2015/09/MonkeyBusinessImagesShutterstock_500x270.jpg)
Outcome Assessments: Measuring Global Disease Activity in Patients with Psoriatic Arthritis - The Rheumatologist
Expanding psoriatic arthritis research at Oxford — Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
![PDF) Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients' health-related quality of life and productivity PDF) Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients' health-related quality of life and productivity](https://i1.rgstatic.net/publication/326995992_Achieving_minimal_disease_activity_in_psoriatic_arthritis_predicts_meaningful_improvements_in_patients'_health-related_quality_of_life_and_productivity/links/5b71b96c299bf14c6d9be41d/largepreview.png)
PDF) Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients' health-related quality of life and productivity
![Reimagining the standard of care in Psoriatic Arthritis and Axial Spondyloarthritis - European Medical Journal Reimagining the standard of care in Psoriatic Arthritis and Axial Spondyloarthritis - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2021/07/eBlast-thumbnails2.png)
Reimagining the standard of care in Psoriatic Arthritis and Axial Spondyloarthritis - European Medical Journal
EULAR 2020 | Laura Coates on the CONTROL trial | psoriatic arthritis | rheumatology.medicinematters.com
![PDF) Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope PDF) Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope](https://i1.rgstatic.net/publication/346493888_Treatment_of_psoriatic_arthritis_with_biologic_and_targeted_synthetic_DMARDs_British_Society_for_Rheumatology_guideline_scope/links/605c62af299bf17367690761/largepreview.png)
PDF) Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope
EULAR Award for Dr Hussein Al-Mossawi — Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
![PDF) Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs PDF) Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs](https://i1.rgstatic.net/publication/361007644_Executive_summary_The_2022_British_Society_for_Rheumatology_guideline_for_the_treatment_of_psoriatic_arthritis_with_biologic_and_targeted_synthetic_DMARDs/links/62ffb0c8aa4b1206fac19bb2/largepreview.png)